Pelvic Castleman disease presenting as vaginal occlusion

Glenn A. Gaunt, Bobbie S. Gostout, Ellen McPhail, William Arthur Cliby

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND: Castleman disease is a lymphoreticular disorder, which may be clinically silent. However, systemic manifestations can occur, which include generalized adenopathy and life-threatening bronchiolitis obliterans. CASE: A woman presented with vaginal mucosal lesions recalcitrant to initial treatment efforts. Progression of the disease required hospitalization for pulmonary involvement. Castleman disease was diagnosed after extensive multidisciplinary evaluation and excision of a pelvic mass. The patient's symptoms dramatically improved postoperatively. CONCLUSION: Castleman disease should be included in the differential diagnosis in patients with paraneoplastic symptoms and a pelvic mass.

Original languageEnglish (US)
Pages (from-to)1082-1085
Number of pages4
JournalObstetrics and Gynecology
Volume100
Issue number5 SUPPL.
DOIs
StatePublished - Nov 1 2002

Fingerprint

Giant Lymph Node Hyperplasia
Bronchiolitis Obliterans
Disease Progression
Hospitalization
Differential Diagnosis
Lung
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Pelvic Castleman disease presenting as vaginal occlusion. / Gaunt, Glenn A.; Gostout, Bobbie S.; McPhail, Ellen; Cliby, William Arthur.

In: Obstetrics and Gynecology, Vol. 100, No. 5 SUPPL., 01.11.2002, p. 1082-1085.

Research output: Contribution to journalArticle

Gaunt, Glenn A. ; Gostout, Bobbie S. ; McPhail, Ellen ; Cliby, William Arthur. / Pelvic Castleman disease presenting as vaginal occlusion. In: Obstetrics and Gynecology. 2002 ; Vol. 100, No. 5 SUPPL. pp. 1082-1085.
@article{2072609762d24aeb92738377b7d5406a,
title = "Pelvic Castleman disease presenting as vaginal occlusion",
abstract = "BACKGROUND: Castleman disease is a lymphoreticular disorder, which may be clinically silent. However, systemic manifestations can occur, which include generalized adenopathy and life-threatening bronchiolitis obliterans. CASE: A woman presented with vaginal mucosal lesions recalcitrant to initial treatment efforts. Progression of the disease required hospitalization for pulmonary involvement. Castleman disease was diagnosed after extensive multidisciplinary evaluation and excision of a pelvic mass. The patient's symptoms dramatically improved postoperatively. CONCLUSION: Castleman disease should be included in the differential diagnosis in patients with paraneoplastic symptoms and a pelvic mass.",
author = "Gaunt, {Glenn A.} and Gostout, {Bobbie S.} and Ellen McPhail and Cliby, {William Arthur}",
year = "2002",
month = "11",
day = "1",
doi = "10.1016/S0029-7844(02)02073-2",
language = "English (US)",
volume = "100",
pages = "1082--1085",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Pelvic Castleman disease presenting as vaginal occlusion

AU - Gaunt, Glenn A.

AU - Gostout, Bobbie S.

AU - McPhail, Ellen

AU - Cliby, William Arthur

PY - 2002/11/1

Y1 - 2002/11/1

N2 - BACKGROUND: Castleman disease is a lymphoreticular disorder, which may be clinically silent. However, systemic manifestations can occur, which include generalized adenopathy and life-threatening bronchiolitis obliterans. CASE: A woman presented with vaginal mucosal lesions recalcitrant to initial treatment efforts. Progression of the disease required hospitalization for pulmonary involvement. Castleman disease was diagnosed after extensive multidisciplinary evaluation and excision of a pelvic mass. The patient's symptoms dramatically improved postoperatively. CONCLUSION: Castleman disease should be included in the differential diagnosis in patients with paraneoplastic symptoms and a pelvic mass.

AB - BACKGROUND: Castleman disease is a lymphoreticular disorder, which may be clinically silent. However, systemic manifestations can occur, which include generalized adenopathy and life-threatening bronchiolitis obliterans. CASE: A woman presented with vaginal mucosal lesions recalcitrant to initial treatment efforts. Progression of the disease required hospitalization for pulmonary involvement. Castleman disease was diagnosed after extensive multidisciplinary evaluation and excision of a pelvic mass. The patient's symptoms dramatically improved postoperatively. CONCLUSION: Castleman disease should be included in the differential diagnosis in patients with paraneoplastic symptoms and a pelvic mass.

UR - http://www.scopus.com/inward/record.url?scp=0036849126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036849126&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(02)02073-2

DO - 10.1016/S0029-7844(02)02073-2

M3 - Article

C2 - 12423813

AN - SCOPUS:0036849126

VL - 100

SP - 1082

EP - 1085

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5 SUPPL.

ER -